======= LDB2 =======
== Gene Information ==
* **Official Symbol**: LDB2
* **Official Name**: LIM domain binding 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9079|9079]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O43679|O43679]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=LDB2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LDB2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/603450|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Binds to the LIM domain of a wide variety of LIM domain- containing transcription factors.
|LIM bind|
|LIM domain binding|
|epithelial structure maintenance|
|cell leading edge|
|RNA polymerase II activating transcription factor binding|
|somatic stem cell population maintenance|
|hair follicle development|
|skin epidermis development|
|hair cycle process|
|molting cycle process|
|transcription coregulator activity|
|hair cycle|
|molting cycle|
|stem cell population maintenance|
|maintenance of cell number|
|tissue homeostasis|
|transcription factor complex|
|multicellular organismal homeostasis|
|anatomical structure homeostasis|
|enzyme binding|
|skin development|
|epidermis development|
|positive regulation of cellular component biogenesis|
|regulation of cell migration|
|nucleolus|
|negative regulation of transcription by RNA polymerase II|
|regulation of kinase activity|
|regulation of cell motility|
|regulation of cellular component biogenesis|
|regulation of transferase activity|
|regulation of locomotion|
|regulation of cellular component movement|
|epithelium development|
|negative regulation of transcription, DNA-templated|
|positive regulation of transcription by RNA polymerase II|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|positive regulation of transcription, DNA-templated|
|negative regulation of biosynthetic process|
|regulation of phosphorylation|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|homeostatic process|
|negative regulation of gene expression|
|positive regulation of RNA metabolic process|
|tissue development|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp332|Adefovir 20μM R07 exp332]]|1.77|
|[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|1.99|
|[[:results:exp17|DABN 20μM R00 exp17]]|2.24|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 15076
* **Expression level (log2 read counts)**: -0.82
{{:chemogenomics:nalm6 dist.png?nolink |}}